LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.031623
 36.54 17.25 503 2679 0.1877 0.5894
MN20160310_N02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 36.54 17.25 1188 2679 0.4433 0.7885
MN20160310_N02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 38.51 17.25 925 2906 0.3183 0.7132
MN20160310_N02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 38.51 17.25 956 2906 0.3290 0.7209
MN20160310_N02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 38.51 17.25 544 2906 0.1872 0.5946
MN20160310_N02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 38.51 17.25 1203 2906 0.4140 0.7752
MN20160310_N02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 40.48 17.25 932 3125 0.2982 0.7020
MN20160310_N02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 40.48 17.25 958 3125 0.3065 0.7083
MN20160310_N02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 40.48 17.25 620 3125 0.1984 0.6120
MN20160310_N02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 40.48 17.25 1208 3125 0.3865 0.7619
MN20160310_N02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 42.45 17.25 936 3504 0.2671 0.6836
MN20160310_N02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 42.45 17.25 959 3504 0.2737 0.6890
MN20160310_N02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 42.45 17.25 667 3504 0.1904 0.6108
MN20160310_N02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 42.45 17.25 1228 3504 0.3505 0.7443
MN20160310_N02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 44.42 17.25 936 3895 0.2403 0.6666
MN20160310_N02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 44.42 17.25 961 3895 0.2467 0.6722
MN20160310_N02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 44.42 17.25 722 3895 0.1853 0.6122
MN20160310_N02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 44.42 17.25 1244 3895 0.3193 0.7283
MN20160310_N02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 46.39 17.25 960 4141 0.2318 0.6624
MN20160310_N02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 46.39 17.25 979 4141 0.2364 0.6665
MN20160310_N02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 46.39 17.25 809 4141 0.1953 0.6268
MN20160310_N02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 46.39 17.25 1270 4141 0.3067 0.7223
MN20160310_N02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 48.36 17.25 967 4390 0.2203 0.6550
MN20160310_N02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 48.36 17.25 988 4390 0.2250 0.6595
MN20160310_N02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 48.36 17.25 996 4390 0.2269 0.6612
MN20160310_N02
F10